Stockscreener 앱 받기
192.39
0.59%
1.13
전일 마감가:
$191.26
열려 있는:
$191
하루 거래량:
1.24M
Relative Volume:
0.47
시가총액:
$55.14B
수익:
$21.39B
순이익/손실:
$1.61B
주가수익비율:
34.60
EPS:
5.56
순현금흐름:
$2.55B
1주 성능:
-0.31%
1개월 성능:
+8.76%
6개월 성능:
-14.16%
1년 성능:
-17.52%
1일 변동 폭
$190.83
$192.98
1주일 범위
$183.72
$193.99
52주 변동 폭
$163.33
$251.99
벡톤 디킨슨 Stock (BDX) Company Profile
명칭
Becton Dickinson Co
전화
(201) 847-6800
주소
ONE BECTON DR, FRANKLIN LAKES
BDX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
192.39 | 54.82B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ISRG
Intuitive Surgical Inc
|
466.86 | 162.93B | 9.15B | 2.63B | 1.99B | 7.17 |
|
RMD
Resmed Inc
|
277.05 | 40.09B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
80.17 | 39.01B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
250.73 | 17.80B | 2.96B | 487.70M | 344.00M | 6.68 |
벡톤 디킨슨 Stock (BDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-05-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-07-11 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-06-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 재개 | Raymond James | Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 재개 | Goldman | Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-07 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-02-07 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-05-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 개시 | Deutsche Bank | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-06-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-04-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-19 | 재개 | BofA/Merrill | Buy |
| 2018-01-05 | 업그레이드 | Citigroup | Sell → Neutral |
| 2018-01-05 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2017-12-29 | 재확인 | Deutsche Bank | Buy |
모두보기
벡톤 디킨슨 주식(BDX)의 최신 뉴스
Becton Dickinson gains amid reports it's evaluating separating life sciences unit - MSN
Is Becton, Dickinson And Company Stock Underperforming The S&P 500? - Barchart.com
Should you wait for a breakout in Becton Dickinson and CompanyEarnings Recap Summary & Precise Trade Entry Recommendations - Newser
Does Becton Dickinson and Company show high probability of reboundJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
Published on: 2025-09-04 22:00:36 - Newser
Becton Dickinson & Co To Go Ex-Dividend On September 8th, 2025 With 1.04 USD Dividend Per Share - 富途牛牛
Becton Dickinson at Wells Fargo Conference: Strategic Growth and Innovation - Investing.com
Becton, Dickinson and Company’s (BDX) Strategic Positioning in the Evolving Healthcare Landscape - AInvest
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Infusion Pump Market to Reach USD 23.13 Billion by 2032, Driven by Rising Chronic Disease Burden & Tech Innovation | SNS Insider - GlobeNewswire Inc.
Regression analysis insights on Becton Dickinson and Company performanceM&A Rumor & AI Optimized Trade Strategies - Newser
Combining machine learning predictions for Becton Dickinson and CompanyWeekly Gains Summary & Growth Focused Stock Reports - Newser
Becton Dickinson Stock Plunges 2.5% Amid PAD Initiatives Ranked 359th in 310M Trading Volume - AInvest
Why Becton Dickinson and Company is moving todayEarnings Beat & Risk Managed Investment Entry Signals - Newser
Becton, Dickinson & Co Is Paying a $85M Settlement to Investors — Here’s How to Get Your Share - TradingView
What Becton Dickinson (BDX)'s Revenue Miss and Ongoing Buybacks Signal for Shareholder Value - simplywall.st
Using data models to predict Becton Dickinson and Company stock movement2025 Market Sentiment & Free AI Powered Buy and Sell Recommendations - Newser
Will Becton Dickinson and Company benefit from macro trends2025 Geopolitical Influence & Daily Stock Trend Watchlist - Newser
Pattern recognition hints at Becton Dickinson and Company upsideDay Trade & Technical Pattern Based Signals - Newser
SEC Form SC 13G/A filed by Becton Dickinson and Company (Amendment) - Quantisnow
Becton Dickinson and Company stock chart pattern explainedJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Intraday pattern recognizer results for Becton Dickinson and CompanyGlobal Markets & AI Driven Price Predictions - Newser
Bullish Becton Dickinson Insiders Loaded Up On US$1.36m Of Stock - 富途牛牛
Zeus Names New Chief Executive Officer - Quantisnow
SEC Form 425 filed by Becton Dickinson and Company - Quantisnow
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care - Quantisnow
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home - Quantisnow
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs - Quantisnow
What MACD signals say about Becton Dickinson and CompanyWatch List & Free Verified High Yield Trade Plans - Newser
Becton, Dickinson and Company (BDX) Generated Lower-Than-Expected Revenue in Q2 - MSN
Tools to monitor Becton Dickinson and Company recovery probability2025 Big Picture & Weekly High Return Opportunities - Newser
Chart based analysis of Becton Dickinson and Company trends2025 Major Catalysts & Breakout Confirmation Trade Signals - Newser
Published on: 2025-08-28 16:05:43 - Newser
Becton Dickinson Options Implied Volatility Surges: What Does it Mean? - AInvest
Are Options Traders Betting on a Big Move in Becton Dickinson Stock? - Yahoo Finance
Breakout Traders Target Becton Dickinson and Company on Recovery Setup getLinesFromResByArray error: size == 0 - classian.co.kr
Here's Why Becton Dickinson (BDX) is a Strong Value Stock - Yahoo Finance
Becton Dickinson Insider Sells Shares Amid Undervalued Stock - AInvest
Becton Dickinson Stock Price, Quotes and Forecasts | NYSE:BDX - Benzinga
Becton Dickinson & Co. stock underperforms Monday when compared to competitors - MarketWatch
Can trapped investors hope for a rebound in Becton Dickinson and CompanyPortfolio Gains Summary & Growth Focused Entry Point Reports - Newser
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
벡톤 디킨슨 (BDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.18%
자본화:
|
볼륨(24시간):